ResMed (RMD) PT Raised to $150 at BofA/Merrill Lynch

October 25, 2019 9:23 AM EDT Send to a Friend

BofA/Merrill Lynch analyst Lyanne Harrison ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

ResMed (RMD) PT Raised to $150 at BofA/Merrill Lynch

Member Login

Free News Feed